Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 8572269Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Internal Medicine
- Pharmacology
NIH Funding · FY2025
Linked Award Amount
$2.2M
Full award amounts, FY2025
Award Records
4
Records listing this PI
Award-Linked Rank
#5,555
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Alexis R. Demonbreun as a PI. Multi-PI records show the full award amount for context.
- 5R01HL167813-03R01Extracellular matrix regulation of cellular crosstalk in cardiac fibrosis$707Kaward amount
- 1R01CA294703-01A1R01Role of BNIP3 and mitophagy in muscle atrophy and cancer cachexia$698.1Kaward amount
- 1R21TR005472-01R21Development of anti-LTBP4 as a biologic to treat Limb Girdle Muscular Dystrophy 2C$440Kaward amount
- $400Kaward amount
Award organizations
Organizations that administered FY2025 awards listing Alexis R. Demonbreun as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardNorthwestern University
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #7145
- 2025$2M Cumulative Funding
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
- 2026$5M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Alexis R. Demonbreun.